Skip to main content
Top

Current Rheumatology Reports

Issue 7/2013

Content (7 Articles)

CRYSTAL ARTHRITIS (MH PILLINGER, SECTION EDITOR)

Update on Oxalate Crystal Disease

Elizabeth C. Lorenz, Clement J. Michet, Dawn S. Milliner, John C. Lieske

PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)

Current Perspectives on Ophthalmic Manifestations of Childhood Rheumatic Diseases

Neal V. Palejwala, Steven Yeh, Sheila T. Angeles-Han

PEDIATRIC RHEUMATOLOGY (TJA LEHMAN, SECTION EDITOR)

Tocilizumab in Pediatric Rheumatology: The Clinical Experience

Reut Gurion, Nora G. Singer

ANTIPHOSPHOLIPID SYNDROME (RAS ROUBEY, SECTION EDITOR)

Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies

Laura Andreoli, Micaela Fredi, Cecilia Nalli, Silvia Piantoni, Rossella Reggia, Francesca Dall’Ara, Franco Franceschini, Angela Tincani

Open Access SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Osteoimmunology and Bone Homeostasis: Relevance to Spondyloarthritis

Steven R. Goldring

SYSTEMIC LUPUS ERYTHEMATOSUS (M PETRI, SECTION EDITOR)

Ten Developments in the Use of Biologicals for Systemic Lupus Erythematosus

Daniel J. Wallace

COMPLEMENTARY AND ALTERNATIVE MEDICINE (SL KOLASINSKI, SECTION EDITOR)

Manipulative Therapy (Feldenkrais, Massage, Chiropractic Manipulation) for Neck Pain

Christopher Plastaras, Seth Schran, Natasha Kim, Deborah Darr, Mary Susan Chen

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine